stoxline Quote Chart Rank Option Currency Glossary
  
Deep Medicine Acquisition Corp. (DMAQ)
2.96  -5.43 (-64.72%)    01-31 16:00
Open: 7.54
High: 7.69
Volume: 73,881
  
Pre. Close: 8.39
Low: 2.96
Market Cap: 13(M)
Technical analysis
2024-03-08 4:51:25 PM
Short term     
Mid term     
Targets 6-month :  9.85 1-year :  13.8
Resists First :  8.43 Second :  11.81
Pivot price 8.86
Supports First :  2.96 Second :  2.46
MAs MA(5) :  7.28 MA(20) :  9.57
MA(100) :  11.19 MA(250) :  11.05
MACD MACD :  -1.3 Signal :  -0.9
%K %D K(14,3) :  17.2 D(3) :  21.2
RSI RSI(14): 15.4
52-week High :  19.9 Low :  2.96
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ DMAQ ] has closed below the lower bollinger band by 22.2%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 911.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 7.7 - 7.74 7.74 - 7.78
Low: 2.92 - 2.94 2.94 - 2.96
Close: 2.93 - 2.96 2.96 - 2.99
Company Description

Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

Headline News

Thu, 01 Feb 2024
Deep Medicine Acquisition and TruGolf Complete Business Combination | DealFlow's SPAC News - DealFlow's SPAC News

Thu, 01 Feb 2024
TruGolf, Inc. and Deep Medicine Acquisition Corp. close business combination; TruGolf becomes publicly traded ... - Utah Business

Wed, 31 Jan 2024
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.82% By Investing.com - Investing.com

Thu, 25 Jan 2024
Deep Medicine Acquisition Corp. (DMAQ) Shareholders Approve TruGolf Deal|SPACInsider - SPACInsider

Thu, 18 Jan 2024
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace

Mon, 15 Jan 2024
Deep Medicine Acquisition Slates Vote on TruGolf Deal | DealFlow's SPAC News - DealFlow's SPAC News

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Financial Services
Industry:
Shell Companies
Shares Out 4 (M)
Shares Float 1 (M)
Held by Insiders 74 (%)
Held by Institutions 28.7 (%)
Shares Short 10 (K)
Shares Short P.Month 6 (K)
Stock Financials
EPS -0.13
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.7
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -1.8 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -1 (M)
Levered Free Cash Flow 122 (M)
Stock Valuations
PE Ratio -22.77
PEG Ratio 0
Price to Book value -1.76
Price to Sales 0
Price to Cash Flow -12.95
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android